Skip to main content

Hydroxyurea Use Among Children with Sickle Cell Anemia

CBE ID
3595
Project
Primary Care and Chronic Illness
Endorsed
New or Maintenance
Maintenance
Endorsement and Maintenance (E&M) Cycle
Fall 2020
Is Under Review
No
Measure Description

The percentage of children ages 1 to 18 years with sickle cell anemia (SCA) who were dispensed hydroxyurea for at least 300 days within the measurement year.

  • Measure Type
    Process
    Electronic Clinical Quality Measure (eCQM)
    No
    Level Of Analysis
    Health Plan
    Care Setting
    Other Care Setting (Please specify)
    Numerator

    The number of children ages 1 to 18 years with sickle cell anemia (SCA) who were dispensed hydroxyurea for at least 300 days within the measurement year.

    Denominator

    The number of children ages 1 to 18 years with sickle cell anemia (SCA) within the measurement year.

    Exclusions

    NA

    Testing Data Sources
    Claims Data
  • Most Recent Endorsement Activity
    Endorsed Primary Care and Chronic Illness Fall Cycle 2020
    Initial Endorsement
    Next Planned Maintenance Review
    Primary Care and Chronic Illness Fall 2024
    Endorsement Status
    Endorsed
    Last Updated